Digital Health Validation Lab (DHVL) Develops Network to Support Regulatory Needs of Digital Health Innovators
Published: 20 June 2024
The Digital Health Validation Lab (DHVL) is working with partners to develop a network that will support and enhance the understanding of digital health innovators as they look to navigate the complex regulatory environment with their products.
The Digital Health Validation Lab (DHVL) is working with partners to develop a network that will support and enhance the understanding of digital health innovators as they look to navigate the complex regulatory environment with their products.
The network will aim to identify and address areas considered to be of particular challenge within the digital health regulatory landscape.
The dynamic and rapidly evolving nature of such technologies has given rise to specific regulatory challenges faced by innovators and companies when developing fresh products. By enabling a network that develops regulatory science approaches spanning the entire product development cycle, DHVL aims to help innovators deliver high-impact innovations that can be scaled up to benefit the UK and worldwide healthcare systems.
A key feature of the network will be DHVL’s ability to generate real world clinical evidence to support regulatory submissions. This requirement for the digital health market is rapidly expanding, and is critical in assuring the safety, effectiveness, and compliance of digital health technologies such as apps, medical devices, and software solutions.
A survey has now been launched to help build an understanding of the regulatory needs of digital health innovators. The insights gained through this survey will help to determine the network’s priorities, ensuring that it focuses on priority areas of need.
The network is being developed alongside partners including Canon Medical Research Europe, CENSIS, Filament STAC - Smart Things Accelerator Centre, NHS Greater Glasgow and Clyde, and InnoScot Health.
This development work is funded by Innovate UK as part of its UK Regulatory Science and Innovation Networks programme – a key initiative for harnessing the power of regulatory science to generate evidence and intelligence which informs regulatory policy and practice.
First published: 20 June 2024
